Neolys Develops Blood Test to Help Doctors Decide Radiotherapy Levels for Prostate Cancer

Neolys Develops Blood Test to Help Doctors Decide Radiotherapy Levels for Prostate Cancer
Neolys Diagnostics has developed a blood test to measure patients’ sensitivity to radiation before they receive radiation therapy, a common prostate cancer treatment. The test helps doctors choose a radiation level that a patient’s healthy tissue can withstand — so as little damage as possible is done to that tissue. Doctors have had few ways of judging that amount.

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *